Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

BioPhorum announces formation of Strategic Advisory Board to accelerate industry collaboration

prnewswire.com
PFE Pfizer's SVP Quality Operations is quoted positively about industry collaboration and innovation, but it's in the context of a broader industry initiative, not specific to Pfizer's stock performance. LLY AMGN Amgen is listed as a founding member of BioPhorum's Strategic Advisory Board. The article focuses on industry collaboration and does not provide specific news affecting Amgen's stock. MRK Merck & Co. is named as a founding member of BioPhorum's Strategic Advisory Board. The article discusses industry collaboration, not company-specific financial news.

LONDON, Feb. 5, 2026 /PRNewswire/ -- BioPhorum, the pharmaceutical industry's most trusted collaborative network for change, today announces the formation of its inaugural Strategic Advisory Board.

The Board, which brings together 14 senior executives across pharma, will provide high-level guidance and C-suite perspective, ensuring BioPhorum's work continues to address the most critical needs of the pharmaceutical sector.

The Strategic Advisory Board will serve as a premier forum for members to participate in an open and strategic dialogue, anticipating the most pressing industry-wide challenges and pivotal opportunities, spanning critical areas such as global regulation, new technology and supply chain resilience.

Board appointments represent visionary leadership across the industry including executives from Pfizer, GSK, Eli Lilly, Amgen, Sanofi, Merck, Merck & Co, SK Pharmteco, Fujifilm BioTechnologies, eXmoor, Sartorius, UCB and Cytiva.

Pfizer's SVP Quality Operations, Lynn Bottone, commented: "Innovation thrives when the industry moves in sync. I am delighted to join this Board and its esteemed cohort to help champion the collective value that drives our industry forward. In this era of rapid technological advancement, our ability to share insights and align on standards is exactly what will accelerate the delivery of life-changing treatments to patients globally."

BioPhorum's CEO Deborah Kobewka, commented: "The launch of the Strategic Advisory Board marks a defining milestone in BioPhorum's evolution. As the industry navigates a period of significant volatility and a challenging global investment landscape, the need for clear, executive-led direction has never been greater. By formalizing this high-level counsel, we are ensuring that BioPhorum remains the primary engine for industry alignment, helping our members turn market complexity into a shared roadmap for sustainable growth."

Founding members of BioPhorum's Strategic Advisory Board include:

Notes to Editors:

Media Contact:

[email protected]

About BioPhorum:

BioPhorum brings together leaders from across the biopharmaceutical industry to collaborate on challenges, share best practices, and shape the future of biopharma. Through its forums and initiatives, BioPhorum provides insight, expertise, and practical solutions that help companies accelerate progress and deliver life-changing medicines to patients worldwide.

https://www.biophorum.com/

Logo: https://mma.prnewswire.com/media/2876942/BioPhorum_Logo.jpg

SOURCE BioPhorum